These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26516946)

  • 1. Biological Variations of Lupus Anticoagulant, Antithrombin, Protein C, Protein S, and von Willebrand Factor Assays.
    Shou W; Chen Q; Wu W; Cui W
    Semin Thromb Hemost; 2016 Feb; 42(1):87-92. PubMed ID: 26516946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.
    Vinholt PJ; Nybo M
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):454-7. PubMed ID: 25485787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
    Zürcher M; Sulzer I; Barizzi G; Lämmle B; Alberio L
    Thromb Haemost; 2008 Feb; 99(2):416-26. PubMed ID: 18278194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy.
    Wickström K; Edelstam G; Löwbeer CH; Hansson LO; Siegbahn A
    Scand J Clin Lab Invest; 2004; 64(1):31-40. PubMed ID: 15029874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of storage and thawing conditions on coagulation testing.
    Gosselin RC; Honeychurch K; Kang HJ; Dwyre DM
    Int J Lab Hematol; 2015 Aug; 37(4):551-9. PubMed ID: 25766006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostasis in patients with Behçet's disease.
    Demirer S; Sengül N; Yerdel MA; Tüzüner A; Ulus AT; Gürler A; Bergqvist D; Siegbahn A; Karacagil S
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):570-4. PubMed ID: 10873722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulable state and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with beta-thalassemia major in Kuwait.
    Mustafa NY; Marouf R; Al-Humood S; Al-Fadhli SM; Mojiminiyi O
    Acta Haematol; 2010; 123(1):37-42. PubMed ID: 19940469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations.
    Timm A; Fahrenkrug J; Jørgensen HL; Sennels HP; Goetze JP
    Eur J Haematol; 2014 Jul; 93(1):48-53. PubMed ID: 24571735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic reference intervals in pregnancy.
    Szecsi PB; Jørgensen M; Klajnbard A; Andersen MR; Colov NP; Stender S
    Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal status.
    Franchi F; Biguzzi E; Martinelli I; Bucciarelli P; Palmucci C; D'Agostino S; Peyvandi F
    Thromb Res; 2013 Aug; 132(2):e152-7. PubMed ID: 23920430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
    Verfaillie CJ; De Witte E; Devreese KM
    Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y; Liu Y; Han R; Zhu Z; Zhang Y; Wang X; Wang L; Shen Z
    Thromb Res; 2008; 122(2):161-6. PubMed ID: 18048090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.
    Zhukov O; Popov J; Ramos R; Vause C; Ruden S; Sferruzza A; Dlott J; Sahud M
    Haemophilia; 2009 May; 15(3):788-96. PubMed ID: 19298374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
    Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
    J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
    Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
    J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.